The Hive co-hosts Kristen Scholer and Jon Kelly discuss the top 5 hottest stories in tech and politics. From Melania Trump's appearance at the State of the Union to Mark Zuckerberg's play for local news, The Hive has the latest news you need to know. Melania Trump broke tradition and rode in a separate motorcar from her husband to the State of the Union Tuesday night... just days after news broke that Trump potentially had an affair with porn star Stormy Daniels. Bess Levin of Vanity Fair discusses why Melania can't divorce Trump and how her brand can survive the next three years. Plus, Jeff Bezos attempts to tackle healthcare. Amazon, JPMorgan, and Warren Buffett have teamed up to fix healthcare within their respective companies. Vanity Fair's Nick Bilton says Bezos typically tries a project on the side before going totally mainstream with it and he thinks this deal is the first step in a larger plan.

Share:
More In Politics
Biden Thanks 'Tennessee Three' for 'Standing Up' for Gun Control
Three Tennessee lawmakers who became Democratic heroes for facing expulsion after participating in gun control protests visited the White House on Monday, describing themselves as “representatives of a movement" that is demanding greater restrictions on firearms to save lives.
Speaker McCarthy Faces Big Test as Debt Bill Heads for Vote
Speaker Kevin McCarthy is hurtling toward one of the most consequential weeks of the new House Republican majority as he labors to pass a partisan package that would raise the nation's debt limit by $1.5 trillion in exchange for steep cuts that some in his own party oppose.
Biden Announces 2024 Reelection Bid: 'Let’s Finish This Job'
President Joe Biden on Tuesday formally announced that he is running for reelection in 2024, asking voters to give him more time to “finish this job” he began when he was sworn into office and to set aside their concerns about extending the run of America’s oldest president for another four years.
Supreme Court Set to Decide on Abortion Pill Access
The Supreme Court is facing a self-imposed Friday night deadline to decide whether women’s access to a widely used abortion pill will stay unchanged until a legal challenge to its Food and Drug Administration approval is resolved.
Load More